# CKD-828 Telmisartan Non-Responder Trial

> **NCT01426100** · PHASE3 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 183 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CKD-828 40/2.5mg
- **DRUG:** CKD-828 40/5mg
- **DRUG:** Telmisartan 80mg

## Key facts

- **NCT ID:** NCT01426100
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-08
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426100, "CKD-828 Telmisartan Non-Responder Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01426100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*